Scientist, Bioscience – Cell & Mechanistic Biology
Driven by science and collaboration, you will help advance innovative therapies for patients with haematological cancers.
Jobs in the Netherlands, in English.
10,000+ live jobsOn-site in the Netherlands·Full-time·Added 7 days ago
Still open when we checked on 8 Oct
9 open roles
Full-time
Per the ad.
Developing future oncology medicines through hands-on medicinal chemistry.
Within our Medicinal Chemistry department, we have exciting opportunities for Scientists Chemistry, who are enthusiastic about hands-on laboratory work and enjoy working closely with colleagues in a collaborative environment. These roles offer the chance to apply your expertise, and to make a real impact on the progress of our projects.
Acerta Pharma will be relocating to Amsterdam, with the current move planned for March/April 2027. Until that time, you will be working from our facilities in Oss. After the move, you will be based at our new site in Amsterdam.
Our preference is for the new Senior Scientist to join in January 2027; however, we can be flexible on the starting date depending on your availability.
Scientist Chemistry (bachelor/master) 5X
As a Scientist, you will be part of our Medicinal Chemistry team and focus on the synthesis and analysis of new molecules. You will be the driving force in the lab, contributing to the progress of our projects towards clinical development.
Our oncology research and development hub is anchored by our new state-of-the-art laboratories in One Helix and the adjacent Plus Ultra Amsterdam building, both located on the Amsterdam University Medical Centre (Amsterdam UMC) campus. Our hub is firmly positioned at the heart of the Dutch research community network, creating new opportunities for our people, our science, and the patients we work to transform outcomes for.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
02-okt.-2026
22-nov.-2026
Application
Recruiter contact · With a recruiter
Assessment
Not every role
Some roles, especially graduate roles, add a game-based assessment, a video or telephone interview, or an assessment day.
Interview
A two-way conversation about your skills and suitability for the role, and a chance for you to find out if AstraZeneca is right for you.
Pre-employment screening
Offer
Apply:
If you have any questions about this vacancy, our Recruitment Team (Karin Raadschelders and Caroline van Oppen) are happy to answer your questions. You can contact them via info@werkenbijacertapharma.nl or by phone on +31(0)85 - 047 0244.
We don't work with a fixed closing date: The vacancy will remain online until we have concluded the process.
Please apply immediately - we start up the selection process straight away.
At AstraZeneca Amsterdam, we bring together two research groups, in haemato-oncology and next-generation cell therapy research. Together, they form our Oncology R&D hub in the Netherlands, working closely with colleagues in the US, Canada, Spain and the UK, to develop innovative treatments for patients with cancer.
Our haematology R&D group was born as Acerta Pharma, one of the Netherland's greatest biotech success stories. Its small-molecule BTK inhibitor has been approved by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of Chronic Lymphocytic Leukaemia (CLL) and Mantle Cell Lymphoma (MCL). In Amsterdam approximately 100 colleagues continue the development of new therapies for haematological malignancies under the AstraZeneca brand name.
AstraZeneca's Cell Therapy R&D team focuses on developing next-generation T-cell receptor (TCR) therapies targeting neoantigens in solid tumours. With a team of around 75 scientists, we work on both fully individualized and shared neo-antigen approaches, with the aim of improving outcomes for patients with cancer.